Bank of Ann Arbor’s Novo Nordisk NVO Stock Holding History

Bank of Ann Arbor’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$148K	Buy	+3,900	New	+$180K	0.02%	229

Other funds holding NVO

Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.71B AUM 69.59% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return

Bank of Ann Arbor's NVO Position: Q3 2026 in Review

Bank of Ann Arbor opened a new position in Novo Nordisk (NVO) in Q3 2026: 3,900 shares worth $148K. The stake represents 0.02% of the portfolio and ranks #229 among its holdings.

1,061 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

Bank of Ann Arbor held 3,900 shares of Novo Nordisk worth $148K as of Q3 2026.
Novo Nordisk was a new Bank of Ann Arbor position in Q3 2026.
Novo Nordisk made up 0.02% of Bank of Ann Arbor's portfolio in Q3 2026, its #229 holding.
1,061 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Bank of Ann Arbor's 13F filing for Q3 2026, filed 13 Nov 2026.